JEANNIE FAHLQUIST: Open Payments
NPI 1508029505 · HELENA, MT. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,338 in 44 payments from 11 companies in 2025. Trend: 2023 $656 · 2024 $657 · 2025 $1,338
Food & beverage: $1,338
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 22 | $399 |
| Janssen Biotech, Inc. | 3 | $228 |
| Phathom Pharmaceuticals, Inc. | 4 | $144 |
| Madrigal Pharmaceuticals | 4 | $141 |
| Gilead Sciences, Inc. | 2 | $134 |
| GENZYME CORPORATION | 1 | $117 |
| QOL Medical, LLC | 3 | $67 |
| Takeda Pharmaceuticals U.S.A., Inc. | 2 | $45 |
| Aimmune Therapeutics, Inc. | 1 | $25 |
| Lilly USA, LLC | 1 | $21 |
Products named: TREMFYA, RINVOQ, VOQUEZNA, REZDIFFRA, DUPIXENT, Livdelzi, Sucraid, VIBERZI.
Industry payments across MT — which companies pay providers there.
